{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:37:02Z","timestamp":1771511822418,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012268","name":"proteomass scientific society","doi-asserted-by":"publisher","award":["#PM001\/2019, #PM003\/2016"],"award-info":[{"award-number":["#PM001\/2019, #PM003\/2016"]}],"id":[{"id":"10.13039\/501100012268","id-type":"DOI","asserted-by":"publisher"}]},{"name":"funda\u00e7\u00e3o para a ci\u00eancia e a tecnologia","award":["UIDB\/50006\/2020"],"award-info":[{"award-number":["UIDB\/50006\/2020"]}]},{"name":"funda\u00e7\u00e3o para a ci\u00eancia e a tecnologia","award":["UIDP\/50006\/2020"],"award-info":[{"award-number":["UIDP\/50006\/2020"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["IF\/00007\/2015"],"award-info":[{"award-number":["IF\/00007\/2015"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["SFRH\/BD\/120537\/2016"],"award-info":[{"award-number":["SFRH\/BD\/120537\/2016"]}]},{"DOI":"10.13039\/100007408","name":"Medical Center, University of Pittsburgh","doi-asserted-by":"crossref","award":["P30CA047904"],"award-info":[{"award-number":["P30CA047904"]}],"id":[{"id":"10.13039\/100007408","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Renal neoplasms encompass a variety of malignant and benign tumors, including many with shared characteristics. The diagnosis of these renal neoplasms remains challenging with currently available tools. In this work, we demonstrate the total protein approach (TPA) based on high-resolution mass spectrometry (MS) as a tool to improve the accuracy of renal neoplasm diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Frozen tissue biopsies of human renal tissues [clear cell renal cell carcinoma (<jats:italic>n<\/jats:italic> = 7), papillary renal cell carcinoma (<jats:italic>n<\/jats:italic> = 5), chromophobe renal cell carcinoma (<jats:italic>n<\/jats:italic> = 5), and renal oncocytoma (<jats:italic>n<\/jats:italic> = 5)] were collected for proteome analysis. Normal adjacent renal tissue (NAT, <jats:italic>n<\/jats:italic> = 5) was used as a control. Proteins were extracted and digested using trypsin, and the digested proteomes were analyzed by label-free high-resolution MS (nanoLC-ESI-HR-MS\/MS). Quantitative analysis was performed by comparison between protein abundances of tumors and NAT specimens, and the label-free and standard-free TPA was used to obtain absolute protein concentrations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 205 differentially expressed proteins with the potential to distinguish the renal neoplasms were found. Of these proteins, a TPA-based panel of 24, including known and new biomarkers, was selected as the best candidates to differentiate the neoplasms. As proof of concept, the diagnostic potential of PLIN2, TUBB3, LAMP1, and HK1 was validated using semi-quantitative immunohistochemistry with a total of 128 samples assessed on tissue micro-arrays.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We demonstrate the utility of combining high-resolution MS and the TPA as potential new diagnostic tool in the pathology of renal neoplasms. A similar TPA approach may be implemented in any cancer study with solid biopsies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-021-02071-9","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T01:02:33Z","timestamp":1630890153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Absolute quantitative proteomics using the total protein approach to identify novel clinical immunohistochemical markers in renal neoplasms"],"prefix":"10.1186","volume":"19","author":[{"given":"Susana","family":"Jorge","sequence":"first","affiliation":[]},{"given":"Jos\u00e9 L.","family":"Capelo","sequence":"additional","affiliation":[]},{"given":"William","family":"LaFramboise","sequence":"additional","affiliation":[]},{"given":"Swati","family":"Satturwar","sequence":"additional","affiliation":[]},{"given":"Dimitrios","family":"Korentzelos","sequence":"additional","affiliation":[]},{"given":"Sheldon","family":"Bastacky","sequence":"additional","affiliation":[]},{"given":"Gabriela","family":"Quiroga-Garza","sequence":"additional","affiliation":[]},{"given":"Rajiv","family":"Dhir","sequence":"additional","affiliation":[]},{"given":"Jacek R.","family":"Wi\u015bniewski","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Lodeiro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6032-8679","authenticated-orcid":false,"given":"Hugo M.","family":"Santos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,9,6]]},"reference":[{"issue":"11","key":"2071_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.5858\/arpa.2013-0653-RA","volume":"138","author":"ON Kryvenko","year":"2014","unstructured":"Kryvenko ON, Jorda M, Argani P, Epstein JI. Diagnostic approach to eosinophilic renal neoplasms. Arch Pathol Lab Med. 2014;138(11):1531\u201341. https:\/\/doi.org\/10.5858\/arpa.2013-0653-RA.","journal-title":"Arch Pathol Lab Med."},{"issue":"10","key":"2071_CR2","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.5858\/arpa.2017-0240-RA","volume":"141","author":"A Wu","year":"2017","unstructured":"Wu A. Oncocytic renal neoplasms on resections and core biopsies: our approach to this challenging differential diagnosis. Arch Pathol Lab Med. 2017;141(10):1336\u201341. https:\/\/doi.org\/10.5858\/arpa.2017-0240-RA.","journal-title":"Arch Pathol Lab Med."},{"issue":"1","key":"2071_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014part A: renal, penile, and testicular tumours. Eur Urol. 2016;70(1):93\u2013105. https:\/\/doi.org\/10.1016\/j.eururo.2016.02.029.","journal-title":"Eur Urol."},{"issue":"4","key":"2071_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/jclinpath-2014-202722","volume":"68","author":"JA Gilbertson","year":"2015","unstructured":"Gilbertson JA, Theis JD, Vrana JA, Lachmann H, Wechalekar A, Whelan C, et al. A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue. J Clin Pathol. 2015;68(4):314\u20137. https:\/\/doi.org\/10.1136\/jclinpath-2014-202722.","journal-title":"J Clin Pathol."},{"issue":"4","key":"2071_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00216-007-1486-6","volume":"389","author":"M Bantscheff","year":"2007","unstructured":"Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B. Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem. 2007;389(4):1017\u201331. https:\/\/doi.org\/10.1007\/s00216-007-1486-6.","journal-title":"Anal Bioanal Chem."},{"issue":"12","key":"2071_CR6","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1074\/mcp.M113.037309","volume":"13","author":"JR Wi\u015bniewski","year":"2014","unstructured":"Wi\u015bniewski JR, Hein MY, Cox J, Mann M. A \u201cproteomic ruler\u201d for protein copy number and concentration estimation without spike-in standards. Mol Cell Proteomics. 2014;13(12):3497\u2013506. https:\/\/doi.org\/10.1074\/mcp.M113.037309.","journal-title":"Mol Cell Proteomics."},{"issue":"9","key":"2071_CR7","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1021\/acs.jproteome.5b00523","volume":"14","author":"JR Wi\u015bniewski","year":"2015","unstructured":"Wi\u015bniewski JR, Du\u015b-Szachniewicz K, Ostasiewicz P, Zi\u00f3\u0142kowski P, Rakus D, Mann M. Absolute proteome analysis of colorectal mucosa, adenoma, and cancer reveals drastic changes in fatty acid metabolism and plasma membrane transporters. J Proteome Res. 2015;14(9):4005\u201318. https:\/\/doi.org\/10.1021\/acs.jproteome.5b00523.","journal-title":"J Proteome Res."},{"key":"2071_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jprot.2016.01.016","volume":"136","author":"JR Wi\u015bniewski","year":"2016","unstructured":"Wi\u015bniewski JR, Vildhede A, Nor\u00e9n A, Artursson P. In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes. J Proteomics. 2016;136:234\u201347. https:\/\/doi.org\/10.1016\/j.jprot.2016.01.016.","journal-title":"J Proteomics."},{"issue":"1","key":"2071_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1021\/pr500833v","volume":"14","author":"JR Wi\u015bniewski","year":"2015","unstructured":"Wi\u015bniewski JR, Friedrich A, Keller T, Mann M, Koepsell H. The impact of high-fat diet on metabolism and immune defense in small intestine mucosa. J Proteome Res. 2015;14(1):353\u201365. https:\/\/doi.org\/10.1021\/pr500833v.","journal-title":"J Proteome Res."},{"issue":"12","key":"2071_CR10","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1080\/14789450.2016.1248415","volume":"13","author":"C Chinello","year":"2016","unstructured":"Chinello C, L\u2019imperio V, Stella M, Smith AJ, Bovo G, Grasso A, et al. The proteomic landscape of renal tumors. Expert Rev Proteomics. 2016;13(12):1103\u201320. https:\/\/doi.org\/10.1080\/14789450.2016.1248415.","journal-title":"Expert Rev Proteomics."},{"key":"2071_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.7150\/jca.1.184","volume":"1","author":"VA Valera","year":"2010","unstructured":"Valera VA, Li-Ning-T E, Walter BA, Roberts DD, Linehan WM, Merino MJ. Protein expression profiling in the spectrum of renal cell carcinomas. J Cancer. 2010;1:184\u201396. https:\/\/doi.org\/10.7150\/jca.1.184.","journal-title":"J Cancer."},{"issue":"8","key":"2071_CR12","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1021\/pr800389e","volume":"8","author":"KWM Siu","year":"2009","unstructured":"Siu KWM, DeSouza LV, Scorilas A, Romaschin AD, Honey RJ, Stewart R, et al. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry. J Proteome Res. 2009;8(8):3797\u2013807. https:\/\/doi.org\/10.1021\/pr800389e.","journal-title":"J Proteome Res."},{"issue":"1","key":"2071_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1074\/mcp.M112.020701","volume":"12","author":"O Masui","year":"2013","unstructured":"Masui O, White NMA, DeSouza LV, Krakovska O, Matta A, Metias S, et al. Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance. Mol Cell Proteomics. 2013;12(1):132\u201344. https:\/\/doi.org\/10.1074\/mcp.M112.020701.","journal-title":"Mol Cell Proteomics."},{"key":"2071_CR14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.18632\/oncotarget.1529","volume":"5","author":"NMA White","year":"2014","unstructured":"White NMA, Masui O, DeSouza LV, Krakovska O, Metias S, Romaschin AD, et al. Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma. Oncotarget. 2014;5:506\u201318. https:\/\/doi.org\/10.18632\/oncotarget.1529.","journal-title":"Oncotarget"},{"issue":"6","key":"2071_CR15","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/bjc.2014.24","volume":"110","author":"A Atrih","year":"2014","unstructured":"Atrih A, Mudaliar MAVV, Zakikhani P, Lamont DJ, Huang JT-J, Bray SE, et al. Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling. Br J Cancer. 2014;110(6):1622\u201333. https:\/\/doi.org\/10.1038\/bjc.2014.24.","journal-title":"Br J Cancer."},{"issue":"2","key":"2071_CR16","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s13277-014-2694-2","volume":"36","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Wu F, Ding S, Sun L, Liu Z, Ding K, et al. Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma. Tumor Biol. 2015;36(2):939\u201351. https:\/\/doi.org\/10.1007\/s13277-014-2694-2.","journal-title":"Tumor Biol."},{"issue":"4","key":"2071_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154074","volume":"11","author":"BA Neely","year":"2016","unstructured":"Neely BA, Wilkins CE, Marlow LA, Malyarenko D, Kim Y, Ignatchenko A, et al. Proteotranscriptomic analysis reveals stage specific changes in the molecular landscape of clear-cell renal cell carcinoma. PLoS One. 2016;11(4):e0154074. https:\/\/doi.org\/10.1371\/journal.pone.0154074.","journal-title":"PLoS One."},{"issue":"7","key":"2071_CR18","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1021\/acs.jproteome.9b00248","volume":"18","author":"S Jorge","year":"2019","unstructured":"Jorge S, Capelo JL, LaFramboise W, Dhir R, Lodeiro C, Santos HM. Development of a robust ultrasonic-based sample treatment to unravel the proteome of OCT-embedded solid tumor biopsies. J Proteome Res. 2019;18(7):2979\u201386. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00248.","journal-title":"J Proteome Res."},{"issue":"D1","key":"2071_CR19","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47(D1):D442\u201350. https:\/\/doi.org\/10.1093\/nar\/gky1106.","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"2071_CR20","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26(12):1367\u201372. https:\/\/doi.org\/10.1038\/nbt.1511.","journal-title":"Nat Biotechnol."},{"issue":"12","key":"2071_CR21","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Cox J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc. 2016;11(12):2301\u201319. https:\/\/doi.org\/10.1038\/nprot.2016.136.","journal-title":"Nat Protoc."},{"issue":"9","key":"2071_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13(9):731\u201340. https:\/\/doi.org\/10.1038\/nmeth.3901.","journal-title":"Nat Methods."},{"key":"2071_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-1-4939-7493-1_7","volume-title":"Methods in Molecular Biology","author":"S Tyanova","year":"2018","unstructured":"Tyanova S, Cox J. Perseus: a bioinformatics platform for integrative analysis of proteomics data in cancer research. In: Methods in Molecular Biology; 2018. p. 133\u201348. https:\/\/doi.org\/10.1007\/978-1-4939-7493-1_7."},{"key":"2071_CR24","doi-asserted-by":"publisher","unstructured":"Wi\u015bniewski JR. Label-Free and standard-free absolute quantitative proteomics using the \u201ctotal protein\u201d and \u201cproteomic ruler\u201d approaches. In: Methods in Enzymology: Academic Press Inc.; 2017. p. 49\u201360. https:\/\/doi.org\/10.1016\/bs.mie.2016.10.002.","DOI":"10.1016\/bs.mie.2016.10.002"},{"issue":"2","key":"2071_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/PAP.0000000000000220","volume":"26","author":"M Akhtar","year":"2019","unstructured":"Akhtar M, Al-Bozom IA, Al HT. Papillary renal cell carcinoma (PRCC): an update. Adv Anat Pathol. 2019;26(2):124\u201332. https:\/\/doi.org\/10.1097\/PAP.0000000000000220.","journal-title":"Adv Anat Pathol."},{"issue":"5","key":"2071_CR26","first-page":"525","volume":"31","author":"CY Sun","year":"2010","unstructured":"Sun CY, Zang YC, San YX, Sun W, Zhang L. Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers. Saudi Med J. 2010;31(5):525\u201332. http:\/\/www.matrixscience. .","journal-title":"Saudi Med J."},{"issue":"6","key":"2071_CR27","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1039\/C5MB00020C","volume":"11","author":"F Raimondo","year":"2015","unstructured":"Raimondo F, Corbetta S, Savoia A, Chinello C, Cazzaniga M, Rocco F, et al. Comparative membrane proteomics: a technical advancement in the search of renal cell carcinoma biomarkers. Mol Biosyst. 2015;11(6):1708\u201316. https:\/\/doi.org\/10.1039\/C5MB00020C.","journal-title":"Mol Biosyst."},{"issue":"1","key":"2071_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/s12864-015-1768-x","volume":"16","author":"J Wei\u00dfer","year":"2015","unstructured":"Wei\u00dfer J, Lai ZW, Bronsert P, Kuehs M, Drendel V, Timme S, et al. Quantitative proteomic analysis of formalin\u2013fixed, paraffin\u2013embedded clear cell renal cell carcinoma tissue using stable isotopic dimethylation of primary amines. BMC Genomics. 2015;16(1):559. https:\/\/doi.org\/10.1186\/s12864-015-1768-x.","journal-title":"BMC Genomics."},{"issue":"4","key":"2071_CR29","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1039\/C2MB05372A","volume":"8","author":"F Raimondo","year":"2012","unstructured":"Raimondo F, Morosi L, Chinello C, Perego R, Bianchi C, Albo G, et al. Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples. Mol BioSyst. 2012;8(4):1007\u201316. https:\/\/doi.org\/10.1039\/C2MB05372A.","journal-title":"Mol BioSyst."},{"issue":"18","key":"2071_CR30","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1016\/j.ejca.2010.07.020","volume":"46","author":"J Tostain","year":"2010","unstructured":"Tostain J, Li G, Gentil-Perret A, Gigante M. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment. Eur J Cancer. 2010;46(18):3141\u20138. https:\/\/doi.org\/10.1016\/j.ejca.2010.07.020.","journal-title":"Eur J Cancer."},{"issue":"12","key":"2071_CR31","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1074\/mcp.M900168-MCP200","volume":"8","author":"R Lichtenfels","year":"2009","unstructured":"Lichtenfels R, Dressler SP, Zobawa M, Recktenwald CV, Ackermann A, Atkins D, et al. Systematic comparative protein expression profiling of clear cell renal cell carcinoma. Mol Cell Proteomics. 2009;8(12):2827\u201342. https:\/\/doi.org\/10.1074\/mcp.M900168-MCP200.","journal-title":"Mol Cell Proteomics."},{"issue":"7","key":"2071_CR32","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1021\/pr100236r","volume":"9","author":"DS Kim","year":"2010","unstructured":"Kim DS, Choi YP, Kang S, Gao MQ, Kim B, Park HR, et al. Panel of candidate biomarkers for renal cell carcinoma. J Proteome Res. 2010;9(7):3710\u20139. https:\/\/doi.org\/10.1021\/pr100236r.","journal-title":"J Proteome Res."},{"issue":"3","key":"2071_CR33","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.juro.2012.09.074","volume":"189","author":"TM Morgan","year":"2013","unstructured":"Morgan TM, Seeley EH, Fadare O, Caprioli RM, Clark PE. Imaging the clear cell renal cell carcinoma proteome. J Urol. 2013;189(3):1097\u2013103. https:\/\/doi.org\/10.1016\/j.juro.2012.09.074.","journal-title":"J Urol."},{"issue":"4","key":"2071_CR34","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1039\/c2mb05390j","volume":"8","author":"F Raimondo","year":"2012","unstructured":"Raimondo F, Salemi C, Chinello C, Fumagalli D, Morosi L, Rocco F, et al. Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE. Mol Biosyst. 2012;8(4):1040\u201351. https:\/\/doi.org\/10.1039\/c2mb05390j.","journal-title":"Mol Biosyst."},{"issue":"7-8","key":"2071_CR35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/pmic.201300434","volume":"14","author":"EE Jones","year":"2014","unstructured":"Jones EE, Powers TW, Neely BA, Cazares LH, Troyer DA, Parker AS, et al. MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma. Proteomics. 2014;14(7-8):924\u201335. https:\/\/doi.org\/10.1002\/pmic.201300434.","journal-title":"Proteomics."},{"key":"2071_CR36","doi-asserted-by":"publisher","first-page":"69.e11","DOI":"10.1016\/j.urolonc.2014.06.005","volume":"33","author":"S Lebdai","year":"2015","unstructured":"Lebdai S, Verhoest G, Parikh H, Jacquet SF, Bensalah K, Chautard D, et al. Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma. Urol Oncol Semin Orig Investig. 2015;33:69.e11\u20138. https:\/\/doi.org\/10.1016\/j.urolonc.2014.06.005.","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"5","key":"2071_CR37","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1021\/ac902204k","volume":"82","author":"DJ Johann","year":"2010","unstructured":"Johann DJ, Wei B-R, Prieto DA, Chan KC, Ye X, Valera VA, et al. Combined blood\/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma. Anal Chem. 2010;82(5):1584\u20138. https:\/\/doi.org\/10.1021\/ac902204k.","journal-title":"Anal Chem."},{"key":"2071_CR38","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2147\/OTT.S91953","volume":"9","author":"Y Yao","year":"2016","unstructured":"Yao Y, Lu Z, Song Q, Yang J, Zhao X, Yang P, et al. Metabolism-related enzyme alterations identified by proteomic analysis in human renal cell carcinoma. Onco Targets Ther. 2016;9:1327. https:\/\/doi.org\/10.2147\/OTT.S91953.","journal-title":"Onco Targets Ther."},{"issue":"11-12","key":"2071_CR39","doi-asserted-by":"publisher","first-page":"1700066","DOI":"10.1002\/prca.201700066","volume":"11","author":"Y Song","year":"2017","unstructured":"Song Y, Zhong L, Zhou J, Lu M, Xing T, Ma L, et al. Data-independent acquisition-based quantitative proteomic analysis reveals potential biomarkers of kidney cancer. PROTEOMICS - Clin Appl. 2017;11(11-12):1700066. https:\/\/doi.org\/10.1002\/prca.201700066.","journal-title":"PROTEOMICS - Clin Appl."},{"key":"2071_CR40","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jprot.2013.07.018","volume":"91","author":"G Giribaldi","year":"2013","unstructured":"Giribaldi G, Barbero G, Mandili G, Daniele L, Khadjavi A, Notarpietro A, et al. Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma. J Proteomics. 2013;91:385\u201392. https:\/\/doi.org\/10.1016\/j.jprot.2013.07.018.","journal-title":"J Proteomics."},{"issue":"5","key":"2071_CR41","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1021\/pr900936z","volume":"9","author":"SR Oppenheimer","year":"2010","unstructured":"Oppenheimer SR, Mi D, Sanders ME, Caprioli RM. Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma. J Proteome Res. 2010;9(5):2182\u201390. https:\/\/doi.org\/10.1021\/pr900936z.","journal-title":"J Proteome Res."},{"issue":"1","key":"2071_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10585-015-9758-6","volume":"33","author":"M Gabril","year":"2016","unstructured":"Gabril M, Girgis H, Scorilas A, Rotondo F, Wala S, Bjarnason GA, et al. S100A11 is a potential prognostic marker for clear cell renal cell carcinoma. Clin Exp Metastasis. 2016;33(1):63\u201371. https:\/\/doi.org\/10.1007\/s10585-015-9758-6.","journal-title":"Clin Exp Metastasis."},{"key":"2071_CR43","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/jcmm.13495","volume":"22","author":"Y Qi","year":"2018","unstructured":"Qi Y, Zhang Y, Peng Z, Wang L, Wang K, Feng D, et al. SERPINH1 overexpression in clear cell renal cell carcinoma: association with poor clinical outcome and its potential as a novel prognostic marker. J Cell Mol Med. 2018;22:1224\u201335. https:\/\/doi.org\/10.1111\/jcmm.13495.","journal-title":"J Cell Mol Med."},{"issue":"4","key":"2071_CR44","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nm.3807","volume":"21","author":"T Guo","year":"2015","unstructured":"Guo T, Kouvonen P, Koh CC, Gillet LC, Wolski WE, R\u00f6st HL, et al. Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps. Nat Med. 2015;21(4):407\u201313. https:\/\/doi.org\/10.1038\/nm.3807.","journal-title":"Nat Med."},{"issue":"12","key":"2071_CR45","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00345-018-2309-4","volume":"36","author":"T Klatte","year":"2018","unstructured":"Klatte T, Rossi SH, Stewart GD. Prognostic factors and prognostic models for renal cell carcinoma: a literature review. World J Urol. 2018;36(12):1943\u201352. https:\/\/doi.org\/10.1007\/s00345-018-2309-4.","journal-title":"World J Urol."},{"issue":"10","key":"2071_CR46","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3390\/ijms18102195","volume":"18","author":"K Inamura","year":"2017","unstructured":"Inamura K. Renal Cell Tumors: Understanding their molecular pathological epidemiology and the 2016 WHO classification. Int J Mol Sci. 2017;18(10):2195. https:\/\/doi.org\/10.3390\/ijms18102195.","journal-title":"Int J Mol Sci."},{"issue":"6","key":"2071_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/gcc.22248","volume":"54","author":"A Marsaud","year":"2015","unstructured":"Marsaud A, Dadone B, Ambrosetti D, Baudoin C, Chamorey E, Rouleau E, et al. Dismantling papillary renal cell carcinoma classification: the heterogeneity of genetic profiles suggests several independent diseases. Genes, Chromosom Cancer. 2015;54(6):369\u201382. https:\/\/doi.org\/10.1002\/gcc.22248.","journal-title":"Genes, Chromosom Cancer."},{"issue":"11","key":"2071_CR48","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s12094-008-0276-8","volume":"10","author":"M Valladares Ayerbes","year":"2008","unstructured":"Valladares Ayerbes M, Aparicio Gallego G, D\u00edaz Prado S, Jim\u00e9nez Fonseca P, Garc\u00eda Campelo R, Ant\u00f3n Aparicio LM. Origin of renal cell carcinomas. Clin Transl Oncol. 2008;10(11):697\u2013712. https:\/\/doi.org\/10.1007\/s12094-008-0276-8.","journal-title":"Clin Transl Oncol."},{"issue":"2","key":"2071_CR49","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S0006-291X(02)00662-9","volume":"295","author":"S Mori","year":"2002","unstructured":"Mori S, Takao S, Ikeda R, Noma H, Mataki Y, Wang X, et al. Thymidine phosphorylase suppresses Fas-induced apoptotic signal transduction independent of its enzymatic activity. Biochem Biophys Res Commun. 2002;295(2):300\u20135. https:\/\/doi.org\/10.1016\/S0006-291X(02)00662-9.","journal-title":"Biochem Biophys Res Commun."},{"issue":"7","key":"2071_CR50","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/bjc.2011.74","volume":"104","author":"IV Bijnsdorp","year":"2011","unstructured":"Bijnsdorp IV, Capriotti F, Kruyt FAE, Losekoot N, Fukushima M, Griffioen AW, et al. Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors. Br J Cancer. 2011;104(7):1185\u201392. https:\/\/doi.org\/10.1038\/bjc.2011.74.","journal-title":"Br J Cancer."},{"issue":"9","key":"2071_CR51","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/jjco\/hyl063","volume":"36","author":"T Takayama","year":"2006","unstructured":"Takayama T, Mugiya S, Sugiyama T, Aoki T, Furuse H, Liu H, et al. High levels of thymidine phosphorylase as an independent prognostic factor in renal cell carcinoma. Jpn J Clin Oncol. 2006;36(9):564\u20139. https:\/\/doi.org\/10.1093\/jjco\/hyl063.","journal-title":"Jpn J Clin Oncol."},{"issue":"6","key":"2071_CR52","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1158\/2159-8290.CD-14-1507","volume":"5","author":"B Qiu","year":"2015","unstructured":"Qiu B, Ackerman D, Sanchez DJ, Li B, Ochocki JD, Grazioli A, et al. HIF2\u03b1-dependent lipid storage promotes endoplasmic reticulum homeostasis in clear-cell renal cell carcinoma. Cancer Discov. 2015;5(6):652\u201367. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-1507.","journal-title":"Cancer Discov."},{"issue":"3","key":"2071_CR53","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3390\/cells8030214","volume":"8","author":"I Mylonis","year":"2019","unstructured":"Mylonis I, Simos G, Paraskeva E. Hypoxia-inducible factors and the regulation of lipid metabolism. Cells. 2019;8(3):214. https:\/\/doi.org\/10.3390\/cells8030214.","journal-title":"Cells."},{"issue":"6","key":"2071_CR54","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/bies.20235","volume":"27","author":"V Rybakin","year":"2005","unstructured":"Rybakin V, Clemen CS. Coronin proteins as multifunctional regulators of the cytoskeleton and membrane trafficking. BioEssays. 2005;27(6):625\u201332. https:\/\/doi.org\/10.1002\/bies.20235.","journal-title":"BioEssays."},{"issue":"4","key":"2071_CR55","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5858\/arpa.2011-0472-RA","volume":"136","author":"SS Shen","year":"2012","unstructured":"Shen SS, Truong LD, Scarpelli M, Lopez-Beltran A. Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? Arch Pathol Lab Med. 2012;136(4):410\u20137. https:\/\/doi.org\/10.5858\/arpa.2011-0472-RA.","journal-title":"Arch Pathol Lab Med."},{"issue":"4","key":"2071_CR56","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s12253-015-9898-7","volume":"21","author":"HA Alshenawy","year":"2015","unstructured":"Alshenawy HA. Immunohistochemical panel for differentiating renal cell carcinoma with clear and papillary features. Pathol Oncol Res. 2015;21(4):893\u20139. https:\/\/doi.org\/10.1007\/s12253-015-9898-7.","journal-title":"Pathol Oncol Res."},{"issue":"8","key":"2071_CR57","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/jclinpath-2015-203585","volume":"69","author":"KL Ng","year":"2016","unstructured":"Ng KL, Morais C, Bernard A, Saunders N, Samaratunga H, Gobe G, et al. A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma. J Clin Pathol. 2016;69(8):661\u201371. https:\/\/doi.org\/10.1136\/jclinpath-2015-203585.","journal-title":"J Clin Pathol."},{"issue":"2","key":"2071_CR58","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.gene.2015.03.061","volume":"563","author":"M Mariani","year":"2015","unstructured":"Mariani M, Karki R, Spennato M, Pandya D, He S, Andreoli M, et al. Class III \u03b2-tubulin in normal and cancer tissues. Gene. 2015;563(2):109\u201314. https:\/\/doi.org\/10.1016\/j.gene.2015.03.061.","journal-title":"Gene."},{"issue":"3","key":"2071_CR59","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ajpath.2013.11.007","volume":"184","author":"MC Tsourlakis","year":"2014","unstructured":"Tsourlakis MC, Weigand P, Grupp K, Kluth M, Steurer S, Schlomm T, et al. \u03b2III-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion. Am J Pathol. 2014;184(3):609\u201317. https:\/\/doi.org\/10.1016\/j.ajpath.2013.11.007.","journal-title":"Am J Pathol."},{"key":"2071_CR60","doi-asserted-by":"publisher","unstructured":"Drendel V, Heckelmann B, Schell C, Kook L, Biniossek ML, Werner M, et al. Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomas. Clin Proteomics. 2018;15:25. https:\/\/doi.org\/10.1186\/s12014-018-9200-6.","DOI":"10.1186\/s12014-018-9200-6"},{"issue":"12","key":"2071_CR61","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1016\/j.cellsig.2013.08.035","volume":"25","author":"A Schindler","year":"2013","unstructured":"Schindler A, Foley E. Hexokinase 1 blocks apoptotic signals at the mitochondria. Cell Signal. 2013;25(12):2685\u201392. https:\/\/doi.org\/10.1016\/j.cellsig.2013.08.035.","journal-title":"Cell Signal."},{"issue":"3","key":"2071_CR62","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1007\/s13277-015-4255-8","volume":"37","author":"X He","year":"2016","unstructured":"He X, Lin X, Cai M, Zheng X, Lian L, Fan D, et al. Overexpression of Hexokinase 1 as a poor prognosticator in human colorectal cancer. Tumor Biol. 2016;37(3):3887\u201395. https:\/\/doi.org\/10.1007\/s13277-015-4255-8.","journal-title":"Tumor Biol."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02071-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-021-02071-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02071-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T01:03:26Z","timestamp":1630890206000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-021-02071-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2071"],"URL":"https:\/\/doi.org\/10.1186\/s12916-021-02071-9","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,6]]},"assertion":[{"value":"7 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Broad at the University of Pittsburgh (IRB # 02-077).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}